EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nexalin Technology's enterprise value is $2.44 Mil.
Nexalin Technology's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $0.16 Mil. Therefore, Nexalin Technology's EV-to-Revenue for today is 15.27.
The historical rank and industry rank for Nexalin Technology's EV-to-Revenue or its related term are showing as below:
NXL'
s EV-to-Revenue Range Over the Past 10 Years
Min: -9.08 Med: 0.9 Max: 102.34
Current: 15.26
During the past 4 years, the highest EV-to-Revenue of Nexalin Technology was 102.34. The lowest was -9.08. And the median was 0.90.
NXL's EV-to-Revenue is ranked worse than 84.44% of 829
companies
in the Medical Devices & Instruments industry
Industry Median: 3.17
vs NXL: 15.26
The historical data trend for Nexalin Technology's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nexalin Technology's EV-to-Revenue
For the Medical Devices subindustry, Nexalin Technology's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexalin Technology's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nexalin Technology's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Nexalin Technology's EV-to-Revenue falls into.
Nexalin Technology's current Enterprise Value is $2.44 Mil.
Nexalin Technology's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nexalin Technology's share price for today is $0.7299.
Nexalin Technology's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nexalin Technology EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Nexalin Technology's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Nexalin Technology (Nexalin Technology) Business Description
Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NXL has been successfully added to your 